Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly A K, Golka K, Okkels H, Risch A, Rothman N, Sim E, Taioli E
CPO-Piemonte at the University of Torino, Torino, Italy.
Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52.
The aim of this study was to investigate the association of NAT2 gene polymorphism with bladder cancer using the data derived from the International Project on Genetic Susceptibility to Environmental Carcinogens. Four case control studies conducted in four European countries, plus two case series, one from England and one from Germany, for a total of 1530 cases and 731 controls (all Caucasian) were included. The interaction between NAT2 and bladder cancer considering smoking habits and occupational exposure was studied. There was a significant association between NAT2 and bladder cancer (odds ratio: 1.42, 95% confidence interval: 1.14-1.77), with a slightly significant heterogeneity among studies. However, heterogeneity disappeared when smokers were divided into current and ex-smokers. The risk of cancer was elevated in smokers and occupationally exposed subjects, with the highest risk among slow acetylators. The increase in risk was limited, in fact, to current smokers (odds ratio = 1.74, 95% confidence interval: 0.96-3.15). This analysis confirms that the NAT2 genotype is a risk factor for bladder cancer by interacting with smoking or occupational exposures. Our observation suggests that NAT2 is not a risk factors per se but modulates the effect of carcinogens contained in tobacco smoke (probably arylamines) or associated with occupational exposures.
本研究旨在利用来自国际环境致癌物遗传易感性项目的数据,调查NAT2基因多态性与膀胱癌的关联。纳入了在四个欧洲国家开展的四项病例对照研究,以及两项病例系列研究,一项来自英国,一项来自德国,共计1530例病例和731名对照(均为白种人)。研究了NAT2与膀胱癌之间在吸烟习惯和职业暴露方面的相互作用。NAT2与膀胱癌之间存在显著关联(比值比:1.42,95%置信区间:1.14 - 1.77),各研究之间存在轻微显著的异质性。然而,当将吸烟者分为现吸烟者和既往吸烟者时,异质性消失。吸烟者和职业暴露者患癌风险升高,慢乙酰化者风险最高。实际上,风险增加仅限于现吸烟者(比值比 = 1.74,95%置信区间:0.96 - 3.15)。该分析证实,NAT2基因型通过与吸烟或职业暴露相互作用,是膀胱癌的一个风险因素。我们的观察结果表明,NAT2本身并非风险因素,而是调节烟草烟雾(可能是芳胺)中所含致癌物或与职业暴露相关致癌物的作用。